StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Business UpdateMay 21, 2026, 08:06 AM

Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference

AI Summary

Iovance Biotherapeutics, Inc. announced that its Interim CEO, President and General Counsel, Fred Vogt, and Chief Financial Officer, Corleen Roche, will participate in a fireside chat. The event is part of the 2026 Jefferies Global Healthcare Conference, scheduled for June 4, 2026, at 1:25 p.m. ET in New York, NY. A webcast of the presentation will be available on the company's investor relations website.

Key Highlights

  • Iovance Biotherapeutics executives to present at the 2026 Jefferies Global Healthcare Conference.
  • Interim CEO Fred Vogt and CFO Corleen Roche will participate in a fireside chat.
  • The presentation is scheduled for June 4, 2026.
  • The event will take place at 1:25 p.m. ET in New York, NY.
  • A live and archived webcast will be available on the company's investor relations website.